Bettina Wanko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bettina Wanko has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Michael Stulnig
Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria
3 shared publications - Günther Staffler
AFFiRiS AG, Vienna, Austria
2 shared publications - John Morser
Division of Hematology, Stanford University School of Medicine, Stanford, California, USA; Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA
2 shared publications - Maximilian Zeyda
Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, 1090 Vienna, Austria
2 shared publications Alexander Jürets
Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University Vienna, Vienna, Austria
1 shared publication- Angelika Neuhofer
Christian Doppler Laboratory for Cardio-Metabolic Immunotherapy and Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria
1 shared publication
Latest Publications
- 16 February 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (5) , 1256-1270
Thrombin cleavage of osteopontin initiates osteopontin’s tumor‐promoting activity
- 16 February 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (5) , 1256-1270
Thrombin cleavage of osteopontin initiates osteopontin’s tumor‐promoting activity
- Open Access
- 5 April 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (4) , e0214938
Antibody-mediated targeting of cleavage-specific OPN-T cell interactions
T cells are crucial players in obesity-mediated adipose tissue inflammation. We hypothesized that osteopontin (OPN), an inflammatory protein with enhanced activity when proteolytically cleaved, affects the number of viable T cells in adipose tissue and assessed inhibition of the interaction between T cells and thrombin and matrix metalloproteinases-cleaved OPN using antibodies and postimmune sera. Gene expression of T cell markers in adipose tissue from wild-type (wt) and Spp1-/- (OPN deficient) mice was analyzed after 16 weeks of high fat diet (HFD) or low fat diet (LFD) feeding. CD3, CD8 and OPN gene expression in omental adipose tissue from individuals with obesity was measured. OPN-T cell interactions were assessed with a fluorescence-based adhesion assay and blocked with antibodies targeting OPN. Comparison of T cell gene expression in adipose tissue from wt and Spp1-/- mice showed that OPN affected the number of T cells while in humans, levels of OPN correlated with T cell markers in omental adipose tissue. The interaction between T cells and cleaved OPN was blocked by postimmune sera following OPN peptide vaccinations and with monoclonal antibodies. In conclusion, levels of OPN affected the number of T cells in obesity and antibodies against cleaved OPN antagonize OPN-T cell interactions.
- 5 April 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (4) , e0214938
Open AccessAntibody-mediated targeting of cleavage-specific OPN-T cell interactions
T cells are crucial players in obesity-mediated adipose tissue inflammation. We hypothesized that osteopontin (OPN), an inflammatory protein with enhanced activity when proteolytically cleaved, affects the number of viable T cells in adipose tissue and assessed inhibition of the interaction between T cells and thrombin and matrix metalloproteinases-cleaved OPN using antibodies and postimmune sera. Gene expression of T cell markers in adipose tissue from wild-type (wt) and Spp1-/- (OPN deficient) mice was analyzed after 16 weeks of high fat diet (HFD) or low fat diet (LFD) feeding. CD3, CD8 and OPN gene expression in omental adipose tissue from individuals with obesity was measured. OPN-T cell interactions were assessed with a fluorescence-based adhesion assay and blocked with antibodies targeting OPN. Comparison of T cell gene expression in adipose tissue from wt and Spp1-/- mice showed that OPN affected the number of T cells while in humans, levels of OPN correlated with T cell markers in omental adipose tissue. The interaction between T cells and cleaved OPN was blocked by postimmune sera following OPN peptide vaccinations and with monoclonal antibodies. In conclusion, levels of OPN affected the number of T cells in obesity and antibodies against cleaved OPN antagonize OPN-T cell interactions.
- Open Access
- 14 September 2016
- Published by Elsevier in Immunology Letters
- Vol. 179, 85-94
Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice
- 14 September 2016
- Published by Elsevier in Immunology Letters
- Vol. 179, 85-94
Open AccessPeptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice